HOUSTON, TX / ACCESSWIRE / June 14, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced it has entered i.
Asset Entities Announces Third Episode of The Lounge Podcast With Two-time NFL Superbowl Champion Ray Crockett marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of
Guerrilla RF Reports Record First Quarter 2024 Results and Gross Margin Expansion marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
CORRECTING and REPLACING Guerrilla RF Reports Record First Quarter 2024 Results and Gross Margin Expansion bdtonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bdtonline.com Daily Mail and Mail on Sunday newspapers.